NO813407L - Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse - Google Patents

Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse

Info

Publication number
NO813407L
NO813407L NO813407A NO813407A NO813407L NO 813407 L NO813407 L NO 813407L NO 813407 A NO813407 A NO 813407A NO 813407 A NO813407 A NO 813407A NO 813407 L NO813407 L NO 813407L
Authority
NO
Norway
Prior art keywords
hoe
inactivator
thr
val
amylase
Prior art date
Application number
NO813407A
Other languages
English (en)
Norwegian (no)
Inventor
Laszlo Vertesy
Miroslav Mracek
Gerhard Braunitzer
Heintz Aschauer
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19803038130 external-priority patent/DE3038130A1/de
Priority claimed from DE19813107106 external-priority patent/DE3107106A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO813407L publication Critical patent/NO813407L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO813407A 1980-10-09 1981-10-08 Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse NO813407L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19803038130 DE3038130A1 (de) 1980-10-09 1980-10-09 (alpha) -amylaseinaktivatoren sowie verfahren zu ihrer herstellung
DE19813107106 DE3107106A1 (de) 1981-02-26 1981-02-26 (alpha) -amylaseinaktivator und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
NO813407L true NO813407L (no) 1982-04-13

Family

ID=25788382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO813407A NO813407L (no) 1980-10-09 1981-10-08 Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse

Country Status (9)

Country Link
US (1) US4451455A (fr)
EP (1) EP0049847B1 (fr)
AU (1) AU542795B2 (fr)
CA (1) CA1172978A (fr)
DE (1) DE3169418D1 (fr)
DK (1) DK446481A (fr)
ES (1) ES8207217A1 (fr)
FI (1) FI813108L (fr)
NO (1) NO813407L (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5885899A (ja) * 1981-11-16 1983-05-23 Fujirebio Inc アミラ−ゼインヒビタ−およびその製造法
DE3331860A1 (de) * 1983-09-03 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von tendamistat
FI844289L (fi) * 1984-01-21 1985-07-22 Hoechst Ag Nya polypeptider med -amylashaemmande verkan, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
DE3536182A1 (de) * 1985-10-10 1987-04-16 Hoechst Ag Promotor-anordnung fuer streptomyceten-vektoren
WO1996012730A1 (fr) * 1994-10-20 1996-05-02 Industrial Research Limited Separation d'acides amines et de peptides a partir d'hydrolysats proteiques
CN1882327A (zh) 2003-11-19 2006-12-20 症变治疗公司 含磷的新的拟甲状腺素药
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
AP2007003979A0 (en) * 2004-11-23 2007-06-30 Warner Lambert Co 7-(2h-pyrazol-3-yl)-3,5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for thetreatment of lipidemia
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
CN101663262B (zh) 2006-12-01 2014-03-26 百时美施贵宝公司 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
WO2010093601A1 (fr) 2009-02-10 2010-08-19 Metabasis Therapeutics, Inc. Nouveaux thyromimetiques contenant de l'acide sulfonique et methodes d'utilisation associees
US20130072519A1 (en) 2010-05-21 2013-03-21 Edward Lee Conn 2-phenyl benzoylamides
WO2012027331A1 (fr) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions et procédés pour traiter ou prévenir un syndrome métabolique et des maladies et troubles associés
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP2680874A2 (fr) 2011-03-04 2014-01-08 Pfizer Inc Peptides de type edn3 et utilisations associées
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP2986599A1 (fr) 2013-04-17 2016-02-24 Pfizer Inc. Dérivés de n-pipéridin-3-ylbenzamide dans le traitement des maladies cardiovasculaires
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
KR102431436B1 (ko) 2014-08-29 2022-08-10 테스 파마 에스.알.엘. α-아미노-β-카복시뮤콘산 세미알데히드 데카복실라제의 억제제
WO2016055901A1 (fr) 2014-10-08 2016-04-14 Pfizer Inc. Composés d'amide substitué
WO2018069532A1 (fr) 2016-10-14 2018-04-19 Tes Pharma S.R.L. Inhibiteurs de la semialdéhyde décarboxylase de l'acide alpha-amino-bêta-carboxymuconique
AR117122A1 (es) 2018-11-20 2021-07-14 Tes Pharma S R L INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
BR112021013807A2 (pt) 2019-01-18 2021-11-30 Astrazeneca Ab Inibidores de pcsk9 e seus métodos de uso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5125232B1 (fr) * 1965-02-24 1976-07-29
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung

Also Published As

Publication number Publication date
ES505959A0 (es) 1982-09-01
CA1172978A (fr) 1984-08-21
DK446481A (da) 1982-04-10
AU7615081A (en) 1982-04-22
US4451455A (en) 1984-05-29
FI813108A7 (fi) 1982-04-10
AU542795B2 (en) 1985-03-14
EP0049847A3 (en) 1982-08-25
EP0049847B1 (fr) 1985-03-20
FI813108L (fi) 1982-04-10
ES8207217A1 (es) 1982-09-01
EP0049847A2 (fr) 1982-04-21
DE3169418D1 (en) 1985-04-25

Similar Documents

Publication Publication Date Title
NO813407L (no) Alfa-amylaseinaktivator, fremgangsmaater til dets fremstilling, middel paa basis av denne inaktivator, samt dens anvendelse
JPS6234396B2 (fr)
US11976098B2 (en) Cooked millet prolamin peptide for inhibiting alpha-amylase and alpha-glucosidase
NO844422L (no) Nye polypeptider med alfa-amylasehemmende virkning, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater
JPS643877B2 (fr)
CN118852336A (zh) 一种α-葡萄糖苷酶抑制肽YPIW及其应用
US4019960A (en) Process for the production of a saccharase inhibitor
US4339436A (en) α-Amylase inhibitor from a streptomycete and process for its preparation
US3937817A (en) Pharmaceutical compositions containing a saccharase inhibitor
JPH0365362B2 (fr)
JPH0521092B2 (fr)
US5244807A (en) Production of pseudomonas xa cells containing indolyl-3-alkane alpha-hydroxylase
NO853461L (no) Nye alfa-glukosidaseinhibitor, fremgangsmaate til dens fremstilling, dens anvendelse og farmasoeytiske preparater.
US5000953A (en) Biologically active substance
PL91664B1 (fr)
US3934006A (en) Pharmaceutical compositions comprising saccharase inhibitors
EP0661293A2 (fr) Protéine à action stimulante sur la croissance des cellules et macrophage-chimiotactique, procédé de préparation et utilisation
NZ198570A (en) Alpha-amylase inactivator
US3995026A (en) Amylase inhibitor
NO781267L (no) Alfa-amylase-inhibitor fra en streptomycet og fremgangsmaate til deres utvinning
NO853460L (no) Nye pseudooligosakkarider med alfa-glukosidasehemmende virkning, fremgangsmaate til deres fremstilling og deres anvendelse samt farmasoeytiske preparater.
FI59815B (fi) Foerfarande foer framstaellning av en alfa-amylas-inhibitor med peptidstruktur
NO873385L (no) Oksiran-pseudooligosakkarider, fremgangsmaate til deres fremstilling, deres anvendelse og farmasoeytiske preparater.
DK143414B (da) Fremgangsmaade til fremstilling af en glycosidhydrolase-inhibitor
JP3448334B2 (ja) 新規生理活性物質ピペラスタチンａおよびその製造法